Visit our integrated report online and read about our results, watch videos of Executive Management or create your own PDF.
All about The BioAg Alliance
$36 million North Carolina facility to create 100 new science jobs
April 23 2014
The European Commission has granted marketing approval to GlaxoSmithKline’s new type 2 diabetes medicine, Eperzan® (albiglutide). The drug uses albumin technology from Novozymes to extend the drug’s presence in the patient’s body.
March 31 2014
Low-pH liquefaction is here!
| Copyright © 2014 Novozymes. All Rights Reserved.